Skip to main content
DrugPrice

Byetta

Exenatide

Generic availableDiabetesby AstraZeneca
$359.00
avg cost per claim
-28.6% year-over-year
$89.0M
Medicare Spending
248,000
Total Claims
28,000
Beneficiaries
$3,179.00
Annual Cost/Patient

Why Byetta Costs $359.00 Per Claim

Byetta (Exenatide) is used to treat diabetes. According to CMS Medicare Part D spending data, the program spent $89.0M on this drug, covering 28,000 beneficiaries across 248,000 claims.

A generic version of this drug is available, which means lower-cost alternatives exist. Patients should ask their pharmacist about generic Exenatide or talk to their doctor about therapeutic alternatives that may cost less.

Spending on Byetta decreased by 28.6% year-over-year, likely due to generic competition reducing prices.

Price Breakdown

Avg cost per claim (30-day)$359.00
Avg annual cost per patient$3,179.00
Total Medicare spending$89.0M
Total claims248,000
Beneficiaries28,000

Drug Details

Brand Name
Byetta
Generic Name
Exenatide
Active Ingredient
Exenatide
Manufacturer
AstraZeneca
Dosage Form
N/A
Route
N/A
Condition
Diabetes
FDA Application
BLA125057

Frequently Asked Questions

Byetta (Exenatide) costs an average of $359.00 per claim based on Medicare Part D data. The estimated annual cost per patient is $3,179.00. Actual out-of-pocket costs depend on your insurance plan and pharmacy.

Yes, a generic version of Byetta (Exenatide) is available. Generic medications typically cost 80-95% less than brand-name drugs. Ask your pharmacist about generic Exenatide.

Medicare Part D spent $89.0M on Byetta, covering 28,000 beneficiaries across 248,000 claims. This makes it one of the tracked drugs in the Medicare spending dashboard.

Ask your pharmacist about generic Exenatide, which is typically much cheaper. You can also compare prices at different pharmacies, use prescription discount programs, or ask your doctor about therapeutic alternatives in the same drug class.

Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims.